샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513910

세계의 상업용 바이오테크놀러지 분리 시스템 시장

Commercial Biotechnology Separation Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 273 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

상업용 바이오테크놀러지 분리 시스템 세계 시장은 2030년까지 310억 달러에 이를 것으로 예상

2023년에 253억 달러로 추정되는 상업용 바이오테크놀러지 분리 시스템 세계 시장은 2023년부터 2030년까지 연평균 복합 성장률(CAGR) 2.9%로 성장했으며 2030년에는 310억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 기존 방법은 CAGR 2.7%로 성장을 지속하고, 분석 기간이 끝날 때까지 190억 달러에 이를 것으로 예측됩니다. 현대적 방법 부문은 분석 기간 동안 CAGR 3.3%의 성장이 예상됩니다.

미국 시장은 69억 달러로 추정, 중국은 CAGR 4.8%로 성장 예측

미국 상업용 바이오테크놀러지 분리 시스템 시장은 2023년 69억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 60억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 4.8%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.6%와 2.4%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 2.0%로 성장할 것으로 예측됩니다.

세계 상업용 바이오테크놀러지 분리 시스템 시장 - 주요 동향 및 촉진요인 요약

상업용 바이오테크놀러지 분리 시스템은 생체분자와 단백질의 정제 및 분석에 필수적이며 의약품, 농업, 에너지 등 다양한 분야에서 매우 중요한 역할을 하고 있습니다. 이러한 고급 시스템은 분리 기술의 지속적인 발전과 바이오 의약품에 대한 세계 수요 증가로 필수적입니다. 시장의 성장은 FDA와 같은 규제기관이 정하는 엄격한 적절한 제조 기준(GMP) 가이드라인을 준수하기 위해 정교한 분리 방법에 대한 요구가 높아지고 있음을 뒷받침하고 있습니다. 최근의 동향으로는 Sony Corporation의 SFA-Life Sciences Cloud Platform이나 Tosoh Bioscience GmbH의 Octave BIO 멀티 컬럼 크로마토그래피 시스템 등의 시스템의 개발을 들 수 있습니다. 이러한 혁신은 바이오테크놀러지 분리의 효율성을 높이고 진화하는 업계 표준에 대응하고 급성장하는 생체분자와 단백질 시장을 지원합니다.

바이오테크놀러지 분리 시스템의 채용과 확대는 몇 가지 중요한 요인에 의해 추진되어 바이오테크놀러지 분야 전체에서의 관련성과 유용성의 증대를 확실히 하고 있습니다. 특히 만성질환의 만연과 맞춤형 의료의 추진은 바이오의약품 수요를 높이고 있으며, 치료용 생체분자의 정제에 효과적인 분리 시스템이 필요합니다. 강화 크로마토그래피, 여과, 원심분리 등의 분리 방법의 기술적 진보는 복잡한 생물학적 혼합물을 보다 효율적으로 취급할 수 있게 되었습니다. 또한 엄격한 규제 준수는 바이오테크놀러지 제품의 고순도 및 고품질을 의무화하여 첨단 분리 프로세스의 필요성을 높이고 있습니다. 특히 BRIC 국가 등 신흥 시장에서 바이오테크놀러지 분야를 확대하고 연구개발에 엄청난 투자를 함으로써 고도의 분리기술에 대한 요구를 더욱 자극하고 있습니다.

새로운 생물 제제의 도입과 기존의 바이오 의약품에서 식품, 음식, 화장품, 농업 등 산업으로의 분리 시스템의 응용 확대와 같은 새로운 동향과 추진력은 바이오 테크놀로지 분리 시스템의 적용 범위의 확대를 부각 있습니다. 재료 과학의 발전은 분리 공정의 성능을 향상시키고 바이오테크놀러지 생산에 필수적인 순도 수준과 수율을 향상시킵니다. IoT, AI, 머신러닝을 포함한 디지털 기술을 분리 시스템에 통합하면 작업을 간소화하고 프로세스를 실시간 모니터링하고 최적화할 수 있습니다. 세계의 건강 위기도 치료제 및 백신 제조에서 분리 시스템의 중요한 역할에 스포트라이트를 적용하여 유행에 대비하고 대응하는 분리 시스템의 중요성을 강조합니다. 마지막으로, 자금 조달과 벤처 캐피탈 투자 증가는 첨단 분리 기술의 도입을 가능하게 하고, 혁신을 촉진하고, 첨단 시스템을 쉽게 얻고, 시장 성장과 진화를 더욱 촉진하고 있습니다.

조사 대상 기업 예(주목의 46사)

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.07.24

Global Commercial Biotechnology Separation Systems Market to Reach US$31.0 Billion by 2030

The global market for Commercial Biotechnology Separation Systems estimated at US$25.3 Billion in the year 2023, is expected to reach US$31.0 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Conventional Method, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$19.0 Billion by the end of the analysis period. Growth in the Modern Method segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Commercial Biotechnology Separation Systems Market - Key Trends and Drivers Summarized

Commercial biotechnology separation systems are essential for the purification and analysis of biomolecules and proteins, playing a pivotal role in various sectors including pharmaceuticals, agriculture, and energy. These advanced systems have become integral due to continuous developments in separation technologies and a global increase in demand for biopharmaceutical products. The market's growth is buoyed by the rising need for sophisticated separation methods to adhere to stringent Good Manufacturing Practices (GMP) guidelines set by regulatory bodies like the FDA. Recent advancements include the development of systems such as the SFA - Life Sciences Cloud Platform by Sony Corporation and the Octave BIO multi-column chromatography system by Tosoh Bioscience GmbH. These innovations enhance the efficiency of biotechnological separations, catering to evolving industry standards, and support the burgeoning market for biomolecules and proteins.

The adoption and expansion of biotechnology separation systems are driven by several critical factors, ensuring their increasing relevance and utility across the biotechnology field. Notably, the growing prevalence of chronic diseases and the push towards personalized medicine have escalated the demand for biopharmaceuticals, necessitating effective separation systems for therapeutic biomolecule purification. Technological advancements in separation methods, such as enhanced chromatography, filtration, and centrifugation, allow for more efficient handling of complex biological mixtures. Additionally, strict regulatory compliance mandates high purity and quality in biotechnological products, bolstering the need for advanced separation processes. The expansion of the biotechnology sector, especially in emerging markets like the BRIC countries, coupled with significant investments in research and development, further stimulates the need for sophisticated separation technologies.

Emerging trends and drivers such as the introduction of new biologics and the expansion of separation system applications beyond traditional biopharmaceuticals into industries like food, beverage, cosmetics, and agriculture, highlight the broadening scope of biotechnology separation systems. Advances in material science enhance the performance of separation processes, increasing purity levels and yields crucial for biotechnological production. The integration of digital technologies, including IoT, AI, and machine learning, into separation systems streamlines operations, enabling real-time monitoring and optimization of processes. Global health crises have also spotlighted the vital role of separation systems in manufacturing therapeutics and vaccines, emphasizing their importance in pandemic preparedness and response. Lastly, increased funding and venture capital investments are enabling the adoption of cutting-edge separation technologies, fostering innovation and facilitating the acquisition of advanced systems, further driving the market's growth and evolution.

Select Competitors (Total 46 Featured) -

  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Commercial Biotechnology Separation Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Biopharmaceuticals Spurs Growth of Biotechnology Separation Systems
    • Advancements in Chromatography Techniques Propel Market Growth
    • Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity
    • Technological Innovations in Membrane Filtration Strengthen Business Case for Advanced Separation Systems
    • Government Regulations and Quality Standards Generate Demand for High-Precision Separation Technologies
    • Rising Adoption of Single-Use Technologies Drives Market Adoption
    • Emergence of Continuous Bioprocessing Throws the Spotlight on Efficient Separation Solutions
    • Growing Use of Monoclonal Antibodies Accelerates Demand for Advanced Separation Techniques
    • Increasing Investment in Biotech R&D Sustain Market Growth
    • Adoption of Automation and Robotics in Bioprocessing Fuels Demand for Integrated Separation Systems
    • Expansion of Biosimilars Market Propels Growth of Biotechnology Separation Systems
    • Growing Applications in Cell and Gene Therapy Expand Market Opportunities
    • Impact of Digital Transformation on Process Optimization
    • Increasing Focus on Process Analytical Technology (PAT) Drives Demand for Real-Time Separation Monitoring
    • Challenges in Scale-Up and Commercial Manufacturing Create Opportunities for Modular Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Commercial Biotechnology Separation Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Conventional by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Conventional by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Modern by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Modern by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Food & Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Food & Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Commercial Biotechnology Separation Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Commercial Biotechnology Separation Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by Method - Conventional and Modern - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Commercial Biotechnology Separation Systems by Method - Conventional and Modern Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Commercial Biotechnology Separation Systems by Method - Percentage Breakdown of Value Sales for Conventional and Modern for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Commercial Biotechnology Separation Systems by End-Use - Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Commercial Biotechnology Separation Systems by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics, Agriculture and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제